News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UK's NICE Backs First-line Use of Johnson & Johnson (JNJ)'s Velcade


6/2/2010 6:50:24 AM

Reuters -- Britain's healthcare cost-effectiveness watchdog NICE recommended Johnson & Johnson's (JNJ.N) drug Velcade as a first-line treatment for multiple myeloma in draft guidance issued on Wednesday.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES